AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BeigeneCatalentSarepta TherapeuticsGALAPAGOS NV/STeva Pharmaceutical Industries
SymbolNASDAQ:BGNENYSE:CTLTNASDAQ:SRPTNASDAQ:GLPGNYSE:TEVA
Price Information
Current Price$204.10$76.22$170.15$201.97$11.40
52 Week RangeBuyBuyBuyHoldHold
Beat the Market™ Rank
Overall Score1.11.11.71.21.6
Analysis Score1.32.43.53.22.0
Community Score2.82.33.22.72.6
Dividend Score0.00.00.00.00.0
Ownership Score1.00.01.00.01.0
Earnings & Valuation Score0.60.60.60.02.5
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldHold
Consensus Price Target$202.81$72.33$198.91$229.00$11.50
% Upside from Price Target-0.63% downside-5.10% downside16.90% upside13.38% upside0.88% upside
Trade Information
Market Cap$15.30 billion$11.39 billion$12.98 billion$13.13 billion$12.16 billion
Beta1.291.631.921.191.65
Average Volume297,2461,358,324933,904160,54216,946,994
Sales & Book Value
Annual Revenue$428.21 million$2.52 billion$380.83 million$1.00 billion$16.89 billion
Price / Sales37.074.6934.8413.130.74
CashflowN/A$3.43 per shareN/A$6.23 per share$3.85 per share
Price / CashN/A22.23N/A32.422.96
Book Value$15.87 per share$11.54 per share$10.98 per share$58.75 per share$13.79 per share
Price / Book12.866.6015.503.440.83
Profitability
Net Income$-948,630,000.00$137.40 million$-715,080,000.00$167.83 million$-998,000,000.00
EPS($15.80)$1.62($9.71)$5.46$2.31
Trailing P/E RatioN/A108.89N/A79.52N/A
Forward P/E RatioN/A42.82N/AN/A4.56
P/E GrowthN/A$3.94N/AN/A$0.82
Net Margins-284.45%4.79%-160.96%15.42%-4.73%
Return on Equity (ROE)-68.64%14.58%-64.67%12.45%18.10%
Return on Assets (ROA)-47.15%4.12%-31.92%6.07%4.72%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.08%1.34%0.66%0.01%1.68%
Current Ratio7.96%1.90%8.31%9.28%1.05%
Quick Ratio7.89%1.58%7.75%9.28%0.70%
Ownership Information
Institutional Ownership Percentage63.78%N/A93.10%11.71%48.79%
Insider Ownership Percentage11.00%1.30%5.90%2.91%0.56%
Miscellaneous
Employees3,50012,3004991,00340,039
Shares Outstanding77.77 million154.90 million77.99 million65.25 million1.09 billion
Next Earnings Date8/13/2020 (Estimated)8/25/2020 (Estimated)8/5/2020 (Estimated)7/23/2020 (Estimated)8/5/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.